Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NeuBase Therapeutics, Inc. | Director | Stock option (right to buy) | 37.6K | Sep 9, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NBSE | NeuBase Therapeutics, Inc. | Sep 9, 2022 | 1 | $0 | 4 | Sep 12, 2022 | Director |
NBSE | NeuBase Therapeutics, Inc. | Aug 19, 2021 | 1 | $0 | 4 | Sep 17, 2021 | Director |
NBSE | NeuBase Therapeutics, Inc. | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |
NBSE | NeuBase Therapeutics, Inc. | May 11, 2021 | 0 | $0 | 3 | May 13, 2021 | Director |